ticlopidine has been researched along with Urinary Tract Diseases in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukerji, G | 1 |
| Munasinghe, I | 1 |
| Raza, A | 1 |
| Choe, KS | 1 |
| Jani, AB | 1 |
| Liauw, SL | 1 |
2 other studies available for ticlopidine and Urinary Tract Diseases
| Article | Year |
|---|---|
A survey of the peri-operative management of urological patients on clopidogrel.
Topics: Anesthesia; Clopidogrel; Elective Surgical Procedures; Humans; Intraoperative Care; Medical Staff, H | 2009 |
External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anticoagulants; Clopidogrel; F | 2010 |